Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
14,465 total articles
Bob's Discount Furniture is showing playbook-level execution: steady unit economics, expansion that preserves margins, and customer retention that outperforms peers. For traders who want direct exposure, we lay out an actionable long trade with specific entry, target and stop, and a 180-trading-day horizon tied to clear operational catalysts.
Nebius' announcement of meaningful price increases for on-demand GPU and CPU access combined with a 454% YoY Q2 revenue surge and management's $3.2B full-year revenue guide changes the risk/reward. I upgrade the rating and recommend a mid-term long trade with a clear entry at $234.064, stop at $200.00 and target at $300.00. This is a high-risk, hig…
Alphabet (GOOG) offers a compelling long-term trade: market-leading AI exposure, cloud momentum via multi-billion compute deals, and strong cash generation. The stock trades at $351.55 with a market cap of roughly $4.32 trillion, a P/E of ~17.3 and free cash flow north of $53B—fundamentals that support a disciplined long entry toward $400 over the …
South32's plan to divest non-core assets and refocus capital on higher-return mining operations is a catalyst for a valuation re-rating. We initiate a long idea: buy S32 with an entry at $6.50, target $8.75 and a stop at $5.25. The thesis rests on proceeds funding higher-margin projects and a cleaner growth runway; risks include commodity cyclicali…
Ultralife (ULBI) trades near $5.62 with very low cash on the balance sheet but a healthy current ratio, manageable debt, and a record backlog of $115.1M. The trade here is a tactical long: the company looks capable of funding near-term obligations while operational fixes and backlog conversion can drive revenue and margins. Entry $5.60, stop $4.90,…
Post Holdings is trading near its 52-week low after guidance and category weakness spooked the market. The decline in FY2027 earnings looks amplified by mix shifts and one-time items; the company's $553M free cash flow run-rate, $1.48B adjusted EBITDA outlook and $500M Foodservice EBITDA run-rate give room to stabilize leverage and deliver upside. …
Nvidia remains the center of the AI boom and trades at a premium, but its cash generation, recent product cycle upside and moderating valuation metrics argue for a tactical long. This trade lays out a precise entry, stop and target with a 180-trading-day horizon while acknowledging sizable macro and execution risks.
Costco enters earnings with a strong top-line backdrop and a market that cares about one thing now: distribution and margin direction. At roughly $895, valuation is rich on a trailing P/E near 45, but balance-sheet strength, a 26% ROE, and recurring membership cash flows make this a tactical buy into the catalyst on 09/24/2026. Trade plan: enter $8…
First Majestic (AG) sits on roughly $1.03 billion of cash against a $9.47 billion market cap and a diversified North American asset base. That treasury creates optionality: tuck-ins, bolt-ons or even a transformational consolidation could rerate the stock if management deploys capital accretively. This trade idea proposes a long position at $19.20 …
Post Holdings is trading near its 52-week low on weak cereal volumes and transition noise, yet it generates meaningful free cash flow, trades at single-digit EV/EBITDA and low P/E, and is positioning Foodservice and premium cereal to offset retail pressure. This trade idea lays out a mid-term, data-driven long with a clear entry, stop and upside ta…
Arcturus Therapeutics is a high-risk, high-reward biotech idea. The market currently prices ARCT at about $15.51, giving the company a market cap near $440M and an enterprise value near $264M. With a late-stage mRNA rare-disease program (LUNAR-OTC), a relatively clean balance sheet versus enterprise value, and renewed investor interest in mRNA/LNP …
Calumet (CLMT) is positioned to benefit from favorable macro oil dynamics, structural growth in specialty hydrocarbons and a government-backed push into sustainable aviation fuel (SAF). Balance-sheet moves and falling short interest have already tightened the risk premium; this trade targets a move toward $75 over the next 180 trading days while pr…
IPG Photonics is executing a higher-margin pivot toward medical and advanced solutions. The binding offer for Lumibird Medical and strong recent medical growth argue for meaningful upside to earnings and EV/EBITDA multiple expansion — provided execution and end-market cycles hold. Enter near current levels, target $120 over a 180-trading-day horizo…
SanDisk is trading well below its 52-week high but above the levels that reflected last year's reset. Strong free cash flow, double-digit margins and outsized returns on capital combined with accelerating AI and edge storage demand argue that upside still remains. This trade targets a disciplined pullback entry into a stock that can re-rate as grow…
Intel's rebound in 2026 is backed by a clear revenue recovery and a meaningful optionality tied to memory-cycle exposure. The stock is a buy at $123.38 for a long-term trade that leans on potential upside from SK hynix-related developments and an improving AI-driven demand backdrop — but investors must respect execution risk in Intel Foundry Servic…
Mueller Water Products (MWA) is a cash-generative leader in water transmission, distribution and measurement equipment. At a market cap near $3.43B, a P/E around 15.5 and EV/EBITDA of ~9.4, the stock looks reasonably valued. Short-term technical weakness has pushed the RSI into the mid-20s and created a tactical entry for a mid-term rebound driven …
BioMarin (BMRN) combines a growing blockbuster franchise, newly minted royalty income, and a deep rare-disease pipeline. At a $12.4B market cap and current price near $64, the risk/reward favors a long position into 2027. This trade plan targets regulatory and commercial catalysts, with durable cash generation from Voyzogo and a monetized competiti…
B2Gold (BTG) is a large, low-cost gold producer whose shares trade at an attractive price, but operations have been bumpy in 2026. Rising all-in sustaining costs, site incidents and a temporary production hit at Goose raise the risk profile. Still, near-term catalysts — incoming cash from the Agnico sale, Fekola Regional and Goose ramp-ups and stea…
Xior Student Housing (XIORF) offers a risk-adjusted long opportunity based on low relative valuation, predictable rental cashflows, and near-term catalysts such as semester occupancy updates and potential refinancing windows. The trade uses a mid-term horizon to capture re-rating and operational improvements while controlling downside with a strict…
Enghouse arrives with a clean balance sheet and meaningful cash reserves but continues to wrestle with falling revenue. This trade idea treats the stock as a recovery/safety-first long: limited position size, clearly defined stop, and targets that reward a stabilization or modest rebound in bookings.
ThyssenKrupp Marine Systems (TKMS) looks positioned to benefit from a multi-year upswing in submarine demand and improving project execution. We recommend a long trade to capture near- to mid-term rerating as order momentum converts into higher margins and visible cash flow.
Micron's position as a dominant supplier of DRAM, NAND, and High-Bandwidth Memory to hyperscalers and data centers, combined with a rock-solid balance sheet and massive free cash flow, supports a bullish trade that could double the stock from current levels. This trade plan is actionable with entry, stop, and target, but it assumes memory pricing h…
Manitowoc (MTW) has cleared several technical hurdles, sits near a 52-week high and trades at a modest EV/EBITDA and attractive free cash flow yield. Pairing momentum with a recovery in heavy equipment demand and manageable leverage creates a high-expected-value trade. Entry, stop and target defined for a long-term horizon (46-180 trading days).
Nebius is moving from a build phase into a pricing phase. After reporting 454% year-over-year revenue growth to $582M in Q2 and guiding to $3.2B for the full year with an $8B annualized run rate, management has announced meaningful price increases for GPU and CPU access. With customer prepayments covering 50-60% of capex and 5 GW of contracted powe…
BRC Inc. (BRCC) is showing tangible progress: retail distribution and SKU depth have ramped materially, recently producing 21% sales growth and GAAP breakeven in Q1. Valuation is compressed (P/S ~0.31), the balance sheet is manageable, and short interest has collapsed from multi-million share levels. We upgrade to long with a clear entry, stop and …
